RYTM - Rhythm Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$144.43
DETAILS
HIGH:
$160.00
LOW:
$120.00
MEDIAN:
$154.00
CONSENSUS:
$144.43
UPSIDE:
61.43%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 414,210 | $46.0M | 0.1% | -432,591 | DECREASED |
| Druckenmiller | 203,618 | $22.6M | 0.4% | +203,618 | NEW |
| Cooperman | 30,168 | $3.3M | 0.0% | -2,484 | DECREASED |
| Greenblatt | 5,516 | $612,441 | 0.0% | +668 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-14 | Meeker David P | director, officer: President and CEO | M-Exempt | 50,000 | $6.05 | $302K |
| 2026-09-14 | Meeker David P | director, officer: President and CEO | SELL | 6,439 | $101.75 | $655K |
| 2026-09-14 | Meeker David P | director, officer: President and CEO | SELL | 30,746 | $102.35 | $3.1M |
| 2026-09-14 | Meeker David P | director, officer: President and CEO | SELL | 8,698 | $103.43 | $900K |
| 2026-09-14 | Meeker David P | director, officer: President and CEO | SELL | 1,817 | $104.55 | $190K |
| 2026-09-14 | Meeker David P | director, officer: President and CEO | SELL | 2,300 | $105.19 | $242K |
| 2026-08-31 | Smith Hunter C | officer: Chief Financial Officer | SELL | 23,072 | $104.59 | $2.4M |
| 2026-08-31 | Smith Hunter C | officer: Chief Financial Officer | SELL | 11,514 | $105.37 | $1.2M |
| 2026-08-31 | Smith Hunter C | officer: Chief Financial Officer | SELL | 28,188 | $106.20 | $3.0M |
| 2026-08-31 | Smith Hunter C | officer: Chief Financial Officer | M-Exempt | 57,187 | $25.79 | $1.5M |
| 2026-08-17 | Joshi Manher | officer: Chief Medical Officer | A-Award | 50,000 | $115.44 | $5.8M |
| 2026-08-17 | Joshi Manher | officer | ? | -- | -- | -- |
| 2026-08-17 | Joshi Manher | officer: Chief Medical Officer | A-Award | 25,000 | -- | -- |
| 2026-08-13 | Garfield Alastair | officer: Chief Scientific Officer | SELL | 3,400 | $118.28 | $402K |
| 2026-08-13 | Shulman Joseph | officer: Chief Technical Officer | SELL | 5,079 | $119.75 | $608K |
| 2026-08-13 | Shulman Joseph | officer: Chief Technical Officer | M-Exempt | 2,024 | $6.80 | $14K |
| 2026-08-13 | Garfield Alastair | officer: Chief Scientific Officer | SELL | 2,007 | $116.11 | $233K |
| 2026-08-13 | Garfield Alastair | officer: Chief Scientific Officer | SELL | 1,556 | $117.08 | $182K |
| 2026-08-13 | Garfield Alastair | officer: Chief Scientific Officer | SELL | 800 | $119.17 | $95K |
| 2026-08-12 | Mazabraud Yann | officer: EVP, Head of International | SELL | 3,605 | $114.70 | $413K |
| 2026-08-12 | Mazabraud Yann | officer: EVP, Head of International | SELL | 1,000 | $112.86 | $113K |
| 2026-08-13 | Lee Jennifer Kayden | officer: EVP, Head of North America | M-Exempt | 35,000 | $24.29 | $850K |
| 2026-08-12 | Mazabraud Yann | officer: EVP, Head of International | SELL | 14,568 | $115.43 | $1.7M |
| 2026-08-13 | Lee Jennifer Kayden | officer: EVP, Head of North America | SELL | 75,834 | $117.38 | $8.9M |
| 2026-08-12 | Mazabraud Yann | officer: EVP, Head of International | SELL | 2,300 | $111.80 | $257K |